| scholarly article | Q13442814 |
| P50 | author | Robert J Brummer | Q39189214 |
| P2093 | author name string | Michiel Kleerebezem | |
| Jerry M Wells | |||
| Jan Dekker | |||
| Freddy J Troost | |||
| Jurgen Karczewski | |||
| Irene Konings | |||
| P2860 | cites work | Identification of the transcriptional response of human intestinal mucosa to Lactobacillus plantarum WCFS1 in vivo | Q33357913 |
| P433 | issue | 6 | |
| P921 | main subject | Lactobacillus plantarum | Q1756682 |
| P304 | page(s) | G851-9 | |
| P577 | publication date | 2010-03-11 | |
| P1433 | published in | American Journal of Physiology - Gastrointestinal and Liver Physiology | Q15765756 |
| P1476 | title | Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier | |
| P478 | volume | 298 |
| Q41359141 | A Comparative Characterization of Different Host-sourced Lactobacillus ruminis Strains and Their Adhesive, Inhibitory, and Immunomodulating Functions. |
| Q36764899 | A Possible Interaction Between Systemic and Renal Angiotensinogen in the Control of Blood Pressure |
| Q57490149 | A Review: The Fate of Bacteriocins in the Human Gastro-Intestinal Tract: Do They Cross the Gut-Blood Barrier? |
| Q35615534 | A Selected Lactobacillus rhamnosus Strain Promotes EGFR-Independent Akt Activation in an Enterotoxigenic Escherichia coli K88-Infected IPEC-J2 Cell Model |
| Q38143713 | A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action |
| Q39535671 | Acidic bile salts modulate the squamous epithelial barrier function by modulating tight junction proteins |
| Q35105259 | Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. |
| Q37911576 | An intimate tête-à-tête — How probiotic lactobacilli communicate with the host |
| Q35851354 | Assessing the Intestinal Microbiota in the SHINE Trial. |
| Q35492838 | Beneficial effects of soy milk and fiber on high cholesterol diet-induced alteration of gut microbiota and inflammatory gene expression in rats |
| Q35719834 | Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner |
| Q60920995 | Biological Activities of Lactose-Based Prebiotics and Symbiosis with Probiotics on Controlling Osteoporosis, Blood-Lipid and Glucose Levels |
| Q57825805 | Biological Activities of Lactose-Derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal System |
| Q26777279 | Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders |
| Q58769723 | Broad Bean ( L.) Induces Intestinal Inflammation in Grass Carp ( C. et V) by Increasing Relative Abundances of Intestinal Gram-Negative and Flagellated Bacteria |
| Q28817192 | Can probiotics modulate human disease by impacting intestinal barrier function? |
| Q28828501 | Causality of small and large intestinal microbiota in weight regulation and insulin resistance |
| Q38084051 | Challenges in translational research on probiotic lactobacilli: from in vitro assays to clinical trials |
| Q51853484 | Combination of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 reduces post-myocardial infarction depression symptoms and restores intestinal permeability in a rat model |
| Q36067915 | Comparative genome-based identification of a cell wall-anchored protein from Lactobacillus plantarum increases adhesion of Lactococcus lactis to human epithelial cells |
| Q38065623 | Complex Roles of Caspases in the Pathogenesis of Inflammatory Bowel Disease |
| Q35015665 | Diet alters probiotic Lactobacillus persistence and function in the intestine |
| Q35739226 | Differential Targeting of the E-Cadherin/β-Catenin Complex by Gram-Positive Probiotic Lactobacilli Improves Epithelial Barrier Function |
| Q92526760 | Dysregulation of Intestinal Epithelial Cell RIPK Pathways Promotes Chronic Inflammation in the IBD Gut |
| Q37865162 | E-cadherin: gatekeeper of airway mucosa and allergic sensitization |
| Q37915055 | Early life: gut microbiota and immune development in infancy. |
| Q27324323 | Early mucosal sensing of SIV infection by paneth cells induces IL-1β production and initiates gut epithelial disruption |
| Q36208695 | Early-Life Sugar Consumption Affects the Rat Microbiome Independently of Obesity |
| Q37976700 | Effect of Lactobacilli on Paracellular Permeability in the Gut |
| Q54295733 | Effect of Lactobacillus plantarum on diarrhea and intestinal barrier function of young piglets challenged with enterotoxigenic Escherichia coli K88. |
| Q35588628 | Effects of Lactobacillus johnsonii and Lactobacillus reuteri on gut barrier function and heat shock proteins in intestinal porcine epithelial cells. |
| Q92701900 | Effects of Lactobacillus plantarum and Lactobacillus paracasei on the Peripheral Immune Response in Children with Celiac Disease Autoimmunity: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial |
| Q57479216 | Effects of Probiotic ( 35624) Supplementation on Exercise Performance, Immune Modulation, and Cognitive Outlook in Division I Female Swimmers |
| Q36218453 | Effects of Supplementation of the Synbiotic Ecologic® 825/FOS P6 on Intestinal Barrier Function in Healthy Humans: A Randomized Controlled Trial. |
| Q34379649 | Effects of probiotics supplementation on gastrointestinal permeability, inflammation and exercise performance in the heat. |
| Q90205959 | Efficacy of Lactobacillus rhamnosus GG in treatment of acute pediatric diarrhea: A systematic review with meta-analysis |
| Q37958744 | Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa |
| Q34093834 | Enteric glial cells and their role in the intestinal epithelial barrier |
| Q40102664 | Enterotoxigenic Escherichia coli and probiotics in swine: what the bleep do we know? |
| Q89901094 | Epithelial Toll-like receptors and their role in gut homeostasis and disease |
| Q54351901 | Establishment of tolerance to commensal bacteria requires a complex microbiota and is accompanied by decreased intestinal chemokine expression |
| Q34195561 | Ethanol impairs intestinal barrier function in humans through mitogen activated protein kinase signaling: a combined in vivo and in vitro approach |
| Q38118340 | Ethanol metabolism and its effects on the intestinal epithelial barrier |
| Q39208815 | Etiology of bacterial vaginosis and polymicrobial biofilm formation |
| Q91711356 | Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms |
| Q47885657 | Evaluation of the antidepressant- and anxiolytic-like effects of a hydrophilic extract from the green seaweed Ulva sp. in rats |
| Q35857740 | Exercise and gut immune function: evidence of alterations in colon immune cell homeostasis and microbiome characteristics with exercise training. |
| Q90285388 | Exertional-heat stress-associated gastrointestinal perturbations during Olympic sports: Management strategies for athletes preparing and competing in the 2020 Tokyo Olympic Games |
| Q47422463 | Exploring how a traditional diluted yoghurt drink may mitigate heat strain during medium-intensity intermittent work. - A multidisciplinary study of occupational heat strain |
| Q35882225 | Faecal microbiome in new-onset juvenile idiopathic arthritis |
| Q93104210 | Food Supplements to Mitigate Detrimental Effects of Pelvic Radiotherapy |
| Q58600368 | GG Protects the Epithelial Barrier of Wistar Rats from the Pepsin-Trypsin-Digested Gliadin (PTG)-Induced Enteropathy |
| Q36824148 | Gene expression of Lactobacillus plantarum and the commensal microbiota in the ileum of healthy and early SIV-infected rhesus macaques |
| Q34332869 | Genomic and phenotypic evidence for probiotic influences ofLactobacillus gasserion human health |
| Q46650965 | Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in rats |
| Q28087145 | Gut Microbiome and Obesity: A Plausible Explanation for Obesity |
| Q35670894 | Gut Microbiota and Inflammation |
| Q35025946 | Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target |
| Q92233647 | Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation |
| Q38070950 | Gut microbiota, host health, and polysaccharides |
| Q33831849 | Gut microbiota, probiotics and diabetes. |
| Q34499017 | Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease |
| Q88337692 | High-intensity-exercise-induced intestinal damage is protected by fermented milk supplemented with whey protein, probiotic and pomegranate (Punica granatum L.). |
| Q33715804 | Homeostasis of the gut barrier and potential biomarkers |
| Q34164041 | Host and gut microbiota symbiotic factors: lessons from inflammatory bowel disease and successful symbionts |
| Q35772165 | Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology. |
| Q34679342 | Human Intestinal Barrier Function in Health and Disease |
| Q36542517 | Human oral isolate Lactobacillus fermentum AGR1487 induces a pro-inflammatory response in germ-free rat colons |
| Q37309403 | Human oral isolate Lactobacillus fermentum AGR1487 reduces intestinal barrier integrity by increasing the turnover of microtubules in Caco-2 cells. |
| Q37641493 | Human pathogenic bacteria, fungi, and viruses in Drosophila: disease modeling, lessons, and shortcomings. |
| Q33748237 | Identification of Lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cells. |
| Q39318691 | Identification of TLR2/TLR6 signalling lactic acid bacteria for supporting immune regulation |
| Q52618523 | Identification of specific miRNAs targeting proteins of the apical junctional complex that simulate the probiotic effect of E. coli Nissle 1917 on T84 epithelial cells |
| Q44527892 | Immunological properties of inulin-type fructans |
| Q34256806 | Immunomodulatory effects of Streptococcus suis capsule type on human dendritic cell responses, phagocytosis and intracellular survival |
| Q35596011 | Immunomodulatory mechanisms of lactobacilli |
| Q34639579 | Immunomodulatory properties of Streptococcus and Veillonella isolates from the human small intestine microbiota |
| Q36517607 | Impact of 4 Lactobacillus plantarum capsular polysaccharide clusters on surface glycan composition and host cell signaling |
| Q30373402 | Impedance analysis of GPCR-mediated changes in endothelial barrier function: overview and fundamental considerations for stable and reproducible measurements |
| Q36948517 | In VitroPrevention ofSalmonellaLipopolysaccharide-Induced Damages in Epithelial Barrier Function by VariousLactobacillusStrains |
| Q35133965 | In vitro comparison of the effects of probiotic, commensal and pathogenic strains on macrophage polarization. |
| Q35142904 | In vitro selection and characterization of new probiotic candidates from table olive microbiota. |
| Q28730963 | Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice |
| Q64905805 | Insights into the evolving role of the gut microbiome in nonalcoholic fatty liver disease: rationale and prospects for therapeutic intervention. |
| Q92173384 | International Society of Sports Nutrition Position Stand: Probiotics |
| Q38217233 | Intestinal barrier: A gentlemen's agreement between microbiota and immunity |
| Q38123531 | Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature |
| Q92032230 | Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives |
| Q35245299 | Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease |
| Q27015884 | Intestinal permeability--a new target for disease prevention and therapy |
| Q37980043 | Is the origin of type 1 diabetes in the gut? |
| Q95840421 | Kawasaki disease: pathophysiology and insights from mouse models |
| Q48331515 | L. fermentum CECT 5716 prevents stress-induced intestinal barrier dysfunction in newborn rats. |
| Q35086617 | Lactobacillus GG restoration of the gliadin induced epithelial barrier disruption: the role of cellular polyamines |
| Q35013865 | Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model. |
| Q36964504 | Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet |
| Q56700277 | Lactobacillus kefiranofaciens M1 isolated from milk kefir grains ameliorates experimental colitis in vitro and in vivo |
| Q26745659 | Lactobacillus plantarum WCFS1 and its host interaction: a dozen years after the genome |
| Q58580452 | Lactobacillus plantarum bacteriocin is associated with intestinal and systemic improvements in diet-induced obese mice and maintains epithelial barrier integrity in vitro |
| Q36437115 | Lactobacillus plantarum possesses the capability for wall teichoic acid backbone alditol switching |
| Q99565635 | Lactobacillus plantarum-derived extracellular vesicles induce anti-inflammatory M2 macrophage polarization in vitro |
| Q35150607 | Lactobacillus reuteri I5007 modulates tight junction protein expression in IPEC-J2 cells with LPS stimulation and in newborn piglets under normal conditions |
| Q92343938 | Lactobacillus reuteri V3401 Reduces Inflammatory Biomarkers and Modifies the Gastrointestinal Microbiome in Adults with Metabolic Syndrome: The PROSIR Study |
| Q48169223 | Lactobacillus reuteri strains protect epithelial barrier integrity of IPEC-J2 monolayers from the detrimental effect of enterotoxigenic Escherichia coli |
| Q89989584 | Lactobacillus salivarius BP121 prevents cisplatin‑induced acute kidney injury by inhibition of uremic toxins such as indoxyl sulfate and p‑cresol sulfate via alleviating dysbiosis |
| Q47168538 | Live Faecalibacterium prausnitzii Does Not Enhance Epithelial Barrier Integrity in an Apical Anaerobic Co-Culture Model of the Large Intestine. |
| Q26752371 | Local and Long-Distance Calling: Conversations between the Gut Microbiota and Intra- and Extra-Gastrointestinal Tract Infections |
| Q37594944 | Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive Escherichia coli. |
| Q90446947 | Metabolism of Caprine Milk Carbohydrates by Probiotic Bacteria and Caco-2:HT29⁻MTX Epithelial Co-Cultures and Their Impact on Intestinal Barrier Integrity |
| Q39369182 | Metabolites of Lactobacillus plantarum 2142 prevent oxidative stress-induced overexpression of proinflammatory cytokines in IPEC-J2 cell line. |
| Q38823295 | MicroRNA-320a Strengthens Intestinal Barrier Function and Follows the Course of Experimental Colitis |
| Q37968291 | Microbes and microbial effector molecules in treatment of inflammatory disorders |
| Q58559445 | Microbiome-microglia connections via the gut-brain axis |
| Q37813012 | Microbiota restoration: natural and supplemented recovery of human microbial communities |
| Q34554827 | Migraine associated with gastrointestinal disorders: review of the literature and clinical implications |
| Q64885341 | Modifications in Vaginal Microbiota and Their Influence on Drug Release: Challenges and Opportunities. |
| Q36087082 | New Insights into the Enterococcus faecium and Streptococcus gallolyticus subsp. gallolyticus Host Interaction Mechanisms |
| Q52319687 | New insight and metrics to understand the ontogeny and succession of Lactobacillus plantarum subsp. plantarum and Lactobacillus plantarum subsp. argentoratensis. |
| Q35213837 | Obesity, inflammation, and the gut microbiota |
| Q37122238 | Oral Administration of Probiotics Inhibits Absorption of the Heavy Metal Cadmium by Protecting the Intestinal Barrier |
| Q52575504 | Oral adsorbent AST-120 ameliorates gut environment and protects against the progression of renal impairment in CKD rats. |
| Q40374820 | Pathogen control at the intestinal mucosa - H2O2 to the rescue |
| Q57464618 | Physical and Antibacterial Properties of Sodium Alginate-Sodium Carboxymethylcellulose Films Containing |
| Q37535417 | Potential of Lactobacillus plantarum CCFM639 in Protecting against Aluminum Toxicity Mediated by Intestinal Barrier Function and Oxidative Stress. |
| Q58762646 | Pre-, pro- and synbiotics in cancer prevention and treatment-a review of basic and clinical research |
| Q46267327 | Probiotic Bacteria for Healthier Aging: Immunomodulation and Metabolism of Phytoestrogens |
| Q43691887 | Probiotic Modulation of Innate Cell Pathogen Sensing and Signaling Events. |
| Q55027051 | Probiotic Species in the Modulation of Gut Microbiota: An Overview. |
| Q37915045 | Probiotic modulation of dendritic cells and T cell responses in the intestine |
| Q46279792 | Probiotic strains and mechanistic insights for the treatment of type 2 diabetes. |
| Q34300645 | Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial |
| Q64090528 | Probiotics and Colon Cancer |
| Q38598371 | Probiotics and the Gut Immune System: Indirect Regulation |
| Q24235259 | Probiotics for patients with hepatic encephalopathy |
| Q38946102 | Probiotics for people with hepatic encephalopathy |
| Q38084050 | Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic |
| Q38096174 | Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives |
| Q34637606 | Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients |
| Q37723991 | Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia |
| Q47189424 | Probiotics or Pro-healers the Role of Beneficial Bacteria in Tissue Repair |
| Q35131051 | Probiotics, nuclear receptor signaling, and anti-inflammatory pathways |
| Q37396622 | Protection and Restitution of Gut Barrier by Probiotics: Nutritional and Clinical Implications |
| Q90223732 | Protective Effect of Probiotic Bacteria and Estrogen in Preventing HIV-1-Mediated Impairment of Epithelial Barrier Integrity in Female Genital Tract |
| Q48761759 | Protective effect of Clostridium tyrobutyricum in acute dextran sodium sulphate-induced colitis: differential regulation of tumour necrosis factor-α and interleukin-18 in BALB/c and severe combined immunodeficiency mice |
| Q38782142 | Protective effects of Lactobacillus plantarum on epithelial barrier disruption caused by enterotoxigenic Escherichia coli in intestinal porcine epithelial cells |
| Q38671651 | Protective effects of chebulic acid on alveolar epithelial damage induced by urban particulate matter |
| Q28253077 | Protective role of gut commensal microbes against intestinal infections |
| Q46564025 | Psychological stress exacerbates NSAID-induced small bowel injury by inducing changes in intestinal microbiota and permeability via glucocorticoid receptor signaling |
| Q34322219 | Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection |
| Q50922715 | Real-time monitoring of trans-epithelial electrical resistance in cultured intestinal epithelial cells: the barrier protection of water-soluble dietary fiber |
| Q104459094 | Receptor-targeted engineered probiotics mitigate lethal Listeria infection |
| Q47620230 | Recipe for IBD: can we use food to control inflammatory bowel disease? |
| Q85721647 | Recombinant invasive Lactococcus lactis can transfer DNA vaccines either directly to dendritic cells or across an epithelial cell monolayer |
| Q33930042 | Recombinant lactic acid bacteria as mucosal biotherapeutic agents |
| Q57117808 | Regional and age dependent changes in gene expression of Toll-like receptors and key antimicrobial defence molecules throughout the gastrointestinal tract of dairy calves |
| Q28235354 | Regulation of Intestinal Immune Responses through TLR Activation: Implications for Pro- and Prebiotics |
| Q34287155 | Regulation of intestinal epithelial permeability by tight junctions. |
| Q34619461 | Regulation of intestinal homeostasis and immunity with probiotic lactobacilli |
| Q98892417 | Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease |
| Q49569061 | Remote Sensing between Liver and Intestine: Importance of Microbial Metabolites |
| Q37924590 | Role of the gut in visceral fat inflammation and metabolic disorders. |
| Q35800667 | Scientific evidence for health effects attributed to the consumption of probiotics and prebiotics: an update for current perspectives and future challenges. |
| Q38020017 | Should probiotics be tested on ex vivo organ culture models? |
| Q24621817 | Side-stream smoking reduces intestinal inflammation and increases expression of tight junction proteins |
| Q91050176 | Sodium in the microenvironment regulates immune responses and tissue homeostasis |
| Q38951937 | Specific inulin-type fructan fibers protect against autoimmune diabetes by modulating gut immunity, barrier function, and microbiota homeostasis |
| Q42576831 | Strain-Specific Features of Extracellular Polysaccharides and Their Impact on Lactobacillus plantarum-Host Interactions |
| Q41933798 | Strain-dependent augmentation of tight-junction barrier function in human primary epidermal keratinocytes by Lactobacillus and Bifidobacterium lysates |
| Q41322319 | Streptococcus salivarius MS-oral-D6 promotes gingival re-epithelialization in vitro through a secreted serine protease. |
| Q58122572 | Structure Dependent-Immunomodulation by Sugar Beet Arabinans via a SYK Tyrosine Kinase-Dependent Signaling Pathway |
| Q37318083 | Supplementation with Lactobacillus plantarum WCFS1 Prevents Decline of Mucus Barrier in Colon of Accelerated Aging Ercc1-/Δ7 Mice |
| Q33613009 | The Gut Microbiota and Autism Spectrum Disorders |
| Q91678242 | The Gut-Brain Axis: Influence of Microbiota on Mood and Mental Health |
| Q90345025 | The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis |
| Q41595627 | The Role of Probiotics in Cancer Treatment: Emphasis on their In Vivo and In Vitro Anti-metastatic Effects |
| Q90148527 | The Role of Probiotics in Colorectal Cancer Management |
| Q92538936 | The Skin and Intestinal Microbiota and Their Specific Innate Immune Systems |
| Q35947598 | The complex interplay of diet, xenobiotics, and microbial metabolism in the gut: Implications for clinical outcomes |
| Q51663001 | The design of probiotic studies to substantiate health claims |
| Q37550508 | The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial |
| Q37890826 | The gut as a regulator of early inflammation in type 1 diabetes |
| Q35614595 | The gut microbiome: a new frontier for alcohol investigation |
| Q35655645 | The gut microbiota and Type 1 Diabetes. |
| Q28080685 | The human neonatal gut microbiome: a brief review |
| Q35494817 | The potential role of probiotics in the management of childhood autism spectrum disorders. |
| Q92712348 | The protective effects of enriched citrulline fermented milk with Lactobacillus helveticus on the intestinal epithelium integrity against Escherichia coli infection |
| Q45037682 | The role of FoxO4 in the relationship between alcohol-induced intestinal barrier dysfunction and liver injury |
| Q37729525 | The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases |
| Q54214888 | The role of the microbiome for human health: from basic science to clinical applications |
| Q38999244 | Toll-like receptor 2 activation by β2→1-fructans protects barrier function of T84 human intestinal epithelial cells in a chain length-dependent manner |
| Q37972675 | Type 1 diabetes: role of intestinal microbiome in humans and mice |
| Q33758617 | Vitamin D/VDR, Probiotics, and Gastrointestinal Diseases |
Search more.